NRGOnc
@nrgonc.bsky.social
Advancing cancer research, improving lives.
Pinned
Registration for the #NRG2026 Winter Meeting is now OPEN! Virtual sessions start the week of Jan 12 and the in-person dates are Jan 22-24. Join us and register soon ↪️https://conta.cc/4qNhcJw
We're discussing Veteran Affairs and Military Treatment Facilities today on our special #VeteransDay episode of The NRG Oncology Podcast! Tune in now: www.NRGOncology.org/Podcast
November 11, 2025 at 1:01 PM
We're discussing Veteran Affairs and Military Treatment Facilities today on our special #VeteransDay episode of The NRG Oncology Podcast! Tune in now: www.NRGOncology.org/Podcast
This #VeteransDay our NRG Oncology podcast co-hosts sit with NRG VA-MTF Subcommittee Chair, Dr. Sandulache, to discuss the subcommittee and their goals as well as clinical research at VA sites. Subscribe or follow: www.NRGOncology.org/Podcast
November 10, 2025 at 12:00 PM
This #VeteransDay our NRG Oncology podcast co-hosts sit with NRG VA-MTF Subcommittee Chair, Dr. Sandulache, to discuss the subcommittee and their goals as well as clinical research at VA sites. Subscribe or follow: www.NRGOncology.org/Podcast
Reposted by NRGOnc
Vinai Gondi, Bridget Koontz, Priya Rastogi, Lisa Lenrow named to NRG Oncology committee leadership (@nrgonc.bsky.social)
https://cancerletter.com/in-brief/20251031_6c/
https://cancerletter.com/in-brief/20251031_6c/
Vinai Gondi, Bridget Koontz, Priya Rastogi, Lisa Lenrow named to NRG Oncology committee leadership - The Cancer Letter
NRG Oncology, an NCI National Clinical Trials Network group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple committees. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not […]
cancerletter.com
November 5, 2025 at 12:00 PM
Vinai Gondi, Bridget Koontz, Priya Rastogi, Lisa Lenrow named to NRG Oncology committee leadership (@nrgonc.bsky.social)
https://cancerletter.com/in-brief/20251031_6c/
https://cancerletter.com/in-brief/20251031_6c/
The November FORTE Fridays newsletter is now available. Check it out here ➡️https://conta.cc/3X7BEay
@fortestudy.bsky.social
@fortestudy.bsky.social
November 7, 2025 at 3:06 PM
The November FORTE Fridays newsletter is now available. Check it out here ➡️https://conta.cc/3X7BEay
@fortestudy.bsky.social
@fortestudy.bsky.social
Registration for the #NRG2026 Winter Meeting is now OPEN! Virtual sessions start the week of Jan 12 and the in-person dates are Jan 22-24. Join us and register soon ↪️https://conta.cc/4qNhcJw
November 6, 2025 at 9:31 PM
Registration for the #NRG2026 Winter Meeting is now OPEN! Virtual sessions start the week of Jan 12 and the in-person dates are Jan 22-24. Join us and register soon ↪️https://conta.cc/4qNhcJw
This #VeteransDay our NRG Oncology podcast co-hosts sit with NRG VA-MTF Subcommittee Chair, Dr. Sandulache, to discuss the subcommittee and their goals as well as clinical research at VA sites. Subscribe or follow: www.NRGOncology.org/Podcast
November 4, 2025 at 7:02 PM
This #VeteransDay our NRG Oncology podcast co-hosts sit with NRG VA-MTF Subcommittee Chair, Dr. Sandulache, to discuss the subcommittee and their goals as well as clinical research at VA sites. Subscribe or follow: www.NRGOncology.org/Podcast
New Episode Alert! Just in time for #PancreaticCancerAwarenessMonth in November, Dr. Sanford discusses the recently activated NRG-GI011 lapse study for dose-escalated RT in LAPC - Tune in: nrgoncology.org/Podcast
November 4, 2025 at 1:58 PM
New Episode Alert! Just in time for #PancreaticCancerAwarenessMonth in November, Dr. Sanford discusses the recently activated NRG-GI011 lapse study for dose-escalated RT in LAPC - Tune in: nrgoncology.org/Podcast
Happy #Halloween! Have you scheduled your yearly #mammogram yet? Early detection can save lives! Don't delay! #BreastCancerAwarenessMonth #BCSM #clinicaltrials #breastcancer #inOctoberWeWearPink #October
October 31, 2025 at 1:30 PM
Happy #Halloween! Have you scheduled your yearly #mammogram yet? Early detection can save lives! Don't delay! #BreastCancerAwarenessMonth #BCSM #clinicaltrials #breastcancer #inOctoberWeWearPink #October
Want to learn about the newest NRG trial in #pancreaticcancer - Our Podcast co-hosts sit with Dr. Sanford to discuss the NRG-GI011 "LAP100" trial of dose escalated RT next week. Follow us where you get your podcasts or listen at www.nrgoncology.org/podcast
October 30, 2025 at 11:30 PM
Want to learn about the newest NRG trial in #pancreaticcancer - Our Podcast co-hosts sit with Dr. Sanford to discuss the NRG-GI011 "LAP100" trial of dose escalated RT next week. Follow us where you get your podcasts or listen at www.nrgoncology.org/podcast
ATTN NRG members: NRG Oncology System Updates – Upcoming Participant Entry Downtime ➡️https://conta.cc/47PhI2g
NRG Oncology System Updates – Upcoming Participant Entry Downtime
Email from NRG Oncology NRG Oncology System Updates – Upcoming Participant Entry Downtime NRG Oncology will be implementing system updates on Sunday, November 9, 2025. Participant randomization to NRG
conta.cc
October 30, 2025 at 5:17 PM
ATTN NRG members: NRG Oncology System Updates – Upcoming Participant Entry Downtime ➡️https://conta.cc/47PhI2g
PRESS RELEASE: NRG Oncology Adds New Leadership Members to Ancillary Projects, Brain Tumor, Breast Cancer, and Patient Advocate Committees - Read more: ow.ly/5qor50XjQaQ
October 29, 2025 at 3:48 PM
PRESS RELEASE: NRG Oncology Adds New Leadership Members to Ancillary Projects, Brain Tumor, Breast Cancer, and Patient Advocate Committees - Read more: ow.ly/5qor50XjQaQ
October is #LiverCancerAwarenessMonth. Recently activated - NRG-GI012 (HELIO-RT) will be testing if adding SBRT to immunotherapy improves survival compared to IO-based systemic therapy alone, in patients with advanced primary liver cancer, or hepatocellular cancer.
October 23, 2025 at 2:00 PM
October is #LiverCancerAwarenessMonth. Recently activated - NRG-GI012 (HELIO-RT) will be testing if adding SBRT to immunotherapy improves survival compared to IO-based systemic therapy alone, in patients with advanced primary liver cancer, or hepatocellular cancer.
Start your Thursday off right with a NEW episode of The NRG Oncology Podcast! Today we discuss all things NCORP and APPs with NRG NCORP PI Deb Bruner.
Tune in and follow: nrgoncology.org/Podcast
Tune in and follow: nrgoncology.org/Podcast
October 16, 2025 at 2:38 PM
Start your Thursday off right with a NEW episode of The NRG Oncology Podcast! Today we discuss all things NCORP and APPs with NRG NCORP PI Deb Bruner.
Tune in and follow: nrgoncology.org/Podcast
Tune in and follow: nrgoncology.org/Podcast
Our October Newsletter edition is available! Read about our #BreastCancer Awareness Features, a special study highlight for ComboMATCH N5, current trials on deck, and more! Check it out: conta.cc/4gQfBhP
October 15, 2025 at 2:26 PM
Our October Newsletter edition is available! Read about our #BreastCancer Awareness Features, a special study highlight for ComboMATCH N5, current trials on deck, and more! Check it out: conta.cc/4gQfBhP
Follow us now to listen to episodes as they air! This THURSDAY, Dr. Deb Bruner talks NCORP, the importance of reaching the community in research & the major role Advanced Practice Providers play in helping us achieve that goal nrgoncology.org/Podcast
October 13, 2025 at 2:53 PM
Follow us now to listen to episodes as they air! This THURSDAY, Dr. Deb Bruner talks NCORP, the importance of reaching the community in research & the major role Advanced Practice Providers play in helping us achieve that goal nrgoncology.org/Podcast
Protocol Activation! Effective October 07, 2025, NRG-GI012 is open to patient entry.
NRG-GI012: Phase III Randomized Trial of IO-Based Systemic Treatment +/- Liver SBRT in Hepatocellular Cancer with Macrovascular Invasion (HELIO-RT)
Learn more:
conta.cc/4gUhIkD
NRG-GI012: Phase III Randomized Trial of IO-Based Systemic Treatment +/- Liver SBRT in Hepatocellular Cancer with Macrovascular Invasion (HELIO-RT)
Learn more:
conta.cc/4gUhIkD
October 7, 2025 at 5:53 PM
Protocol Activation! Effective October 07, 2025, NRG-GI012 is open to patient entry.
NRG-GI012: Phase III Randomized Trial of IO-Based Systemic Treatment +/- Liver SBRT in Hepatocellular Cancer with Macrovascular Invasion (HELIO-RT)
Learn more:
conta.cc/4gUhIkD
NRG-GI012: Phase III Randomized Trial of IO-Based Systemic Treatment +/- Liver SBRT in Hepatocellular Cancer with Macrovascular Invasion (HELIO-RT)
Learn more:
conta.cc/4gUhIkD
On Monday, Sept 29th, we announced the activation of NRG-GY037, a pivotal Phase III randomized trial for patients with high-risk, locally advanced cervical cancer. PI: Jyoti Mayadev, MD, UCSDHealth
Read more: conta.cc/3Iwh00d
Read more: conta.cc/3Iwh00d
October 3, 2025 at 11:57 AM
On Monday, Sept 29th, we announced the activation of NRG-GY037, a pivotal Phase III randomized trial for patients with high-risk, locally advanced cervical cancer. PI: Jyoti Mayadev, MD, UCSDHealth
Read more: conta.cc/3Iwh00d
Read more: conta.cc/3Iwh00d
October is #BreastCancerAwarenessMonth. Whether you are due for your yearly check in October or any other month - consider this a reminder to get screened with a yearly mammogram - early detection is key! Learn more: go.usa.gov/xhWrf
October 1, 2025 at 4:33 PM
October is #BreastCancerAwarenessMonth. Whether you are due for your yearly check in October or any other month - consider this a reminder to get screened with a yearly mammogram - early detection is key! Learn more: go.usa.gov/xhWrf
The NRG Oncology Podcast is looking at the results of our Late-Breaking Session presentations at #ASTRO25 on NRG-LU005 QOL and the proton cohort of NRG-BN001! Follow us now to be in the loop: nrgoncology.org/Podcast @henryfordhealth.bsky.social
September 22, 2025 at 6:08 PM
The NRG Oncology Podcast is looking at the results of our Late-Breaking Session presentations at #ASTRO25 on NRG-LU005 QOL and the proton cohort of NRG-BN001! Follow us now to be in the loop: nrgoncology.org/Podcast @henryfordhealth.bsky.social
NRG has SEVERAL great presentations coming up at #ASTRO25: The NRG Oncology Podcast will dive deeper into results such as the NRG-GU005 and RadComp presentations in the Plenary Session. Learn more and follow: nrgoncology.org/Podcast
September 19, 2025 at 12:04 PM
NRG has SEVERAL great presentations coming up at #ASTRO25: The NRG Oncology Podcast will dive deeper into results such as the NRG-GU005 and RadComp presentations in the Plenary Session. Learn more and follow: nrgoncology.org/Podcast
NEW EPISODE! We are talking precision oncology, clinical research, and industry collaboration with
@weldeiry.bsky.social sky.social
Follow our podcast: nrgoncology.org/Podcast
@americancancersoc.bsky.social
@weldeiry.bsky.social sky.social
Follow our podcast: nrgoncology.org/Podcast
@americancancersoc.bsky.social
September 18, 2025 at 3:00 PM
NEW EPISODE! We are talking precision oncology, clinical research, and industry collaboration with
@weldeiry.bsky.social sky.social
Follow our podcast: nrgoncology.org/Podcast
@americancancersoc.bsky.social
@weldeiry.bsky.social sky.social
Follow our podcast: nrgoncology.org/Podcast
@americancancersoc.bsky.social
NRG Oncology Aims to Move the Needle in Prostate Cancer Outcomes. September is #ProstateCancerAwarenessMonth. The theme of this year’s campaign is “awareness needs action.” We have multiple active studies in the prostate cancer space. Learn more ➡️https://ow.ly/Hcqt50WXwn6
September 17, 2025 at 7:43 PM
NRG Oncology Aims to Move the Needle in Prostate Cancer Outcomes. September is #ProstateCancerAwarenessMonth. The theme of this year’s campaign is “awareness needs action.” We have multiple active studies in the prostate cancer space. Learn more ➡️https://ow.ly/Hcqt50WXwn6
Welcome new NRG PAC member Lauren Hilliard! In our Sept newsletter, she discusses her role as a clinical research coordinator for endometrial & cervical cancers, placing a strong emphasis on the importance of patients' voices. ow.ly/ynsv50WXv5Q
September 16, 2025 at 6:51 PM
Welcome new NRG PAC member Lauren Hilliard! In our Sept newsletter, she discusses her role as a clinical research coordinator for endometrial & cervical cancers, placing a strong emphasis on the importance of patients' voices. ow.ly/ynsv50WXv5Q
Our September eNewsletter is out! This issue includes updates about our #prostatecancer trials portfolio, upcoming cervical cancer study NRG-GY037, SOROCk & more - Advocate Angle, PSC column and @fortestudy.bsky.social updates! Check it out ↪️https://conta.cc/45LwfLF
September 16, 2025 at 2:02 PM
Our September eNewsletter is out! This issue includes updates about our #prostatecancer trials portfolio, upcoming cervical cancer study NRG-GY037, SOROCk & more - Advocate Angle, PSC column and @fortestudy.bsky.social updates! Check it out ↪️https://conta.cc/45LwfLF
NRG NCORP is soliciting LOIs in preparation for the next NCORP pilot grant RFA. Anyone interested in applying must submit a Letter of Intent (LOI) by October 24, 2025. Learn more ➡️https://conta.cc/4nw14Km
September 12, 2025 at 1:36 PM
NRG NCORP is soliciting LOIs in preparation for the next NCORP pilot grant RFA. Anyone interested in applying must submit a Letter of Intent (LOI) by October 24, 2025. Learn more ➡️https://conta.cc/4nw14Km